Bram Rochwerg
Overview
Explore the profile of Bram Rochwerg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
397
Citations
13342
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernando S, Qureshi D, Ante Z, Talarico R, McIsaac D, Urner M, et al.
Crit Care Med
. 2025 Feb;
PMID: 40013851
Objectives: To evaluate 1-year outcomes (mortality, and recurrent hospital and ICU readmission) in adult survivors of COVID-19 critical illness compared with survivors of critical illness from non-COVID-19 pneumonia. Design: Population-based...
2.
McChesney C, Orozco N, Fiorini K, Wong M, Slessarev M, Prager R, et al.
Crit Care Med
. 2025 Feb;
PMID: 40009025
Objectives: To determine the impact of short-acting beta-blocker therapy on outcomes in adult patients with septic shock. Data Sources: We searched MEDLINE, Embase, and unpublished sources from inception to April...
3.
4.
Haddad G, Maslove D, Mbuagbaw L, Belley-Cote E, Rochwerg B
Crit Care Explor
. 2025 Jan;
7(2):e1210.
PMID: 39888591
Importance: While corticosteroid administration in septic shock has been shown to result in faster shock reversal and lower short-term mortality, the role of corticosteroids in the management of cardiogenic shock...
5.
Fernando S, Qureshi D, Talarico R, Fan E, McIsaac D, Vigod S, et al.
Chest
. 2025 Jan;
PMID: 39848569
Background: Surviving COVID-19 critical illness may be associated with important long-term sequelae, but little is known regarding mental health outcomes. Research Question: What is the association between COVID-19 critical illness...
6.
Sevransky J, Barreto E, Bleck T, Chen J, Dellinger R, Deutschman C, et al.
Crit Care Med
. 2025 Jan;
53(1):e1-e3.
PMID: 39774201
No abstract available.
7.
Takaoka A, Johnstone J, Lauzier F, Heels-Ansdell D, Davis M, Zytaruk N, et al.
Trials
. 2024 Dec;
25(1):851.
PMID: 39731129
Background: Understanding site-related factors that influence enrolment within multicenter randomized controlled trials (RCT) may help reduce trial delays and cost over-runs and prevent early trial discontinuation. In this analysis of...
8.
Duhailib Z, Hakeam H, Almossalem A, Alrashidi A, Al Zhrani A, Al Salman H, et al.
Endocr Pract
. 2024 Dec;
PMID: 39725356
Objective: Dysglycemia has deleterious outcomes on critically ill patients with diabetes mellitus (DM). Insulin degludec, an ultralong-acting insulin, is associated with lower rates of hypoglycemia and blood glucose (BG) variability...
9.
Garland A, Li N, Sligl W, Lane A, Thavorn K, Wilcox M, et al.
Crit Care Med
. 2024 Dec;
52(12):1845-1855.
PMID: 39637258
Objectives: Refine the administrative data definition of sepsis in hospitalized patients, including less severe cases. Design And Setting: For each of 1928 infection and 108 organ dysfunction codes used in...
10.
Kilcommons S, Hammal F, Kamaleldin M, Opgenorth D, Fiest K, Karvellas C, et al.
Crit Care Med
. 2024 Dec;
53(2):e384-e399.
PMID: 39631091
Objectives: To summarize the efficacy of midodrine as an adjunctive therapy in critically ill patients. Safety of midodrine was assessed as a secondary outcome. Data Sources: We performed a systematic...